Medication info
Notongpen Plus Mini Tablet

Notongpen Plus Mini Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Hwail Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle 300 tablets/bottle
Approval status
Active

MFDS item code 201310500 · Approved 2013.12.04 · Insurance code 684501030

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients 75 years of age or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children 12 years of age and older: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Hwail Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • moderate to severe chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients 75 years of age or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children 12 years of age and older: The dose should be adjusted according to the patient's degree of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication can place a burden on the liver, so individuals who regularly consume more than three alcoholic drinks a day should consult a doctor or pharmacist before taking it. This medication can rarely cause serious skin reactions, so if a rash or allergic symptoms occur, discontinue use immediately and inform healthcare personnel. The ingredients in this medication may increase the risk of seizures, so patients with a history of seizures or seizure risk factors should use with caution. Rarely, serious allergic reactions such as anaphylaxis may occur, so if sudden difficulty breathing or hives appear, seek medical assistance immediately. Patients with severe respiratory diseases may face the risk of respiratory depression when taking this medication, so administration should be done under medical supervision. Co-administration with alcohol or central nervous system depressants may enhance sedation and respiratory depression, so avoid combining them. Patients with head injuries or those with elevated intracranial pressure may experience worsened symptoms while taking this medication, therefore caution is advised. This medication can cause physical and psychological dependence, so it should be administered under a doctor's supervision for long-term use. Patients with compromised liver function should consult a doctor before taking this medication and take care not to exceed the recommended dosage. Patients with specific genotypes may produce excess active metabolites, increasing the risk of respiratory depression; in such cases, close medical supervision is required. This medication should not be given to children under 12 years old and adolescents under 18 years old after certain surgeries, as there is an increased risk of respiratory depression in children. Patients with sleep apnea or hypoxemia may experience worsened symptoms after taking this medication, thus close monitoring of symptom changes is necessary. This medication can cause hyponatremia, so especially elderly patients or those with risk factors should have their sodium levels in the blood checked regularly. In the case of overdose, serious respiratory depression, seizures, liver damage, etc., may occur, so it is essential to adhere to the prescribed dosages. Women who are pregnant or breastfeeding should consult a doctor before using this medication, especially since it may be transmitted through breast milk and pose risks to the baby. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. This medication may interact with several drugs, so it is necessary to inform healthcare professionals of any other medications currently being taken.

Side effects

Liver damage, acute generalised exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory impairment, tremors, paresthesia, attention deficit, syncope, memory disorders, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual disturbances, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary dysfunction, erectile dysfunction, weakness, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic response, Steven-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, increased prothrombin time, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, stupor, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, pollakiuria, abnormal renal function, oliguria, increased sweating, dysphagia, tongue edema, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal visual field, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, constipation, vomiting, dizziness, dyspnea, stupor, confusion, multiple organ failure, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, hair loss, agitation, nervousness, hyperactivity, panic attack, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, urticaria, rash, bronchospasm, toxic skin necrosis, anaphylaxis, withdrawal symptoms, withdrawal syndrome, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulation disorders, abdominal discomfort, lethargy, pallor, hyperhidrosis, respiratory depression, hypersomnia, coma, cardiac arrest, death

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air entry, and it's best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.